From: 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study
Interval p.i
Mean (SD)
Cumulative urinary excretion
Mean (SD) %IA
1.5 h (0.3)
4.3% (2.1)
4.5 h (0.4)
8.5% (3.2)
22.5 h (1.4)
15.1% (8.1)